Yuki Kawashima

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. pmc Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis
    Yuki Kawashima
    Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA
    Bone 44:648-55. 2009
  2. pmc Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1)
    J Christopher Fritton
    Leni and Peter W May Department of Orthopaedics, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Bone Miner Res 25:235-46. 2010
  3. pmc Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism
    Shoshana Yakar
    Endocrinology Diabetes and Bone Disease, The Mt Sinai School of Medicine, One Gustave L Levy Place, Box 1055, New York, NY 10029 6574, USA
    FASEB J 23:709-19. 2009
  4. pmc Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions
    Shoshana Yakar
    Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
    J Bone Miner Res 24:1481-92. 2009
  5. pmc The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate
    J Christopher Fritton
    Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Biol Chem 285:4709-14. 2010

Collaborators

Detail Information

Publications5

  1. pmc Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis
    Yuki Kawashima
    Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA
    Bone 44:648-55. 2009
    ..Further, these results emphasize the importance of evaluating diabetic bone based on morphology in addition to bone mass...
  2. pmc Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1)
    J Christopher Fritton
    Leni and Peter W May Department of Orthopaedics, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Bone Miner Res 25:235-46. 2010
    ..Interactions between estrogen and the GH/IGF-1 system as related to bone remodeling provide a pathway to minimize degeneration of bone tissue structure and osteoporotic fracture...
  3. pmc Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism
    Shoshana Yakar
    Endocrinology Diabetes and Bone Disease, The Mt Sinai School of Medicine, One Gustave L Levy Place, Box 1055, New York, NY 10029 6574, USA
    FASEB J 23:709-19. 2009
    ..3) IGFBP-3 deficiency resulted in increased linear growth. In summary, each IGF-1 complex constituent appears to play a distinct role in determining skeletal phenotype, with different effects on cortical and trabecular bone compartments...
  4. pmc Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions
    Shoshana Yakar
    Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
    J Bone Miner Res 24:1481-92. 2009
    ....
  5. pmc The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate
    J Christopher Fritton
    Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Biol Chem 285:4709-14. 2010
    ....